A trial looking at whole body MRI scans for prostate cancer that has spread to the bones (WISER-P)
This trial is comparing whole body MRI scans to bone and CT scans to find out which is better at showing how well treatment is working.
Sutton
Available
A trial of BNT113 for head and neck cancer (AHEAD-MERIT)
This trial is comparing BT113 and pembrolizumab to pembrolizumab alone, for squamous cell head and neck cancer.
A trial looking at stereotactic radiotherapy and niraparib for ovarian cancer (SOPRANO)
This trial is looking at stereotactic radiotherapy by itself and followed by niraparib for ovarian cancer that has started to grow again
A trial looking at MK-2870 for non small cell lung cancer that has spread
This trial is comparing chemotherapy with MK-2870 for non small cell lung cancer (NSCLC).
A trial looking at MK-2870 for cancer of the womb (MK-2870-005)
This trial is comparing MK-2870 with chemotherapy for womb cancer that has come back after treatment.
A study of crizotinib for children and young adults with cancer (CRISP)
This study is looking at crizotinib by itself and with temsirolimus for children and young people with cancer.
A study looking at personalised prehabilitation for myeloid leukaemia and myelodysplastic syndrome (PROPEL)
This study is assessing the value of prehabilitation for people with acute myeloid leukaemia and myelodysplastic syndrome.
A trial of chemotherapy, pembrolizumab and lenvatinib for oesophageal cancer has spread (LEAP-014)
This trial is comparing 2 combinations of treatment for cancer of the food pipe (oesophagus) that has spread to another part of the body.
A trial of ipatasertib with standard treatment for breast cancer (FAIM)
This trial is looking at measuring circulating tumour DNA (ctDNA) in the blood from breast cancer.
A trial of datopotamab deruxtecan with or without durvalumab for triple negative breast cancer (TROPION-Breast03)
This trial is comparing datopotamab deruxtecan with and without durvalumab to chemotherapy and immunotherapy.